Clopidogrel Tablet
Product Images NDC 33342-060

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Clopidogrel (NDC 33342-060). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clopidogrel-100s (Clopidogrel 100s)

Clopidogrel is a pharmaceutical drug that is available in the form of 75mg tablets manufactured by Madeods Pharmaceuticals Lid in Baddi, Himachal Pradesh, India. The batch number of this tablet, in particular, is HP/152/073342006012. The pharmacist is required to dispense a medication guide to every patient. The recommended dosage and storage for these tablets are also provided. However, the given text does not provide any other significant pieces of information.*

FDA Label Image

Clopidogrel-30s (Clopidogrel 30s)

Clopidogrel is a medication presented in a bottle of 30 tablets of 75 mg each. Each tablet contains 97.875 mg of clopidogrel bisulfate, USP, which is equivalent to 75 mg of clopidogrel base. It is recommended to dispense the enclosed medication guide to each patient. The usual dosage areas see package insert. This medication should be stored at 20° to 25°C (68° to 77° F), although excursions permitted to 15° to 30° C (59° to 86° F) [see USP Controlled room temperature]. It is manufactured by Macleods Pharmaceuticals Ltd. for Macleods Pharma USA, Inc. The batch number is not available.*

FDA Label Image

Clopidogrel-500s (Clopidogrel 500s)

Each Cleody tablet contains 75 mg of clopidogrel bisulfate, USP equivalent to 75 mg of clopidogrel base. The USP Controlled Room Temperature for storing is 20°C to 25°C (68°F to 77°F) with permitted excursions to 15°C to 30°C (59°F to 86°F). The usual dosage is defined in the package insert. Pharmacists are instructed to dispense the enclosed Medication Guide to patients. This medication is manufactured by Macleods Pharmaceuticals Ltd. with a code no. of HP/152/07, and is distributed by Macleods Pharma USA, Inc. in Plainsboro, NJ. This batch of Cleody has a shelf life of expiring on 30 X 23 mm.*

FDA Label Image

Clopidogrel-90s (Clopidogrel 90s)

FDA Label Image

Figure-03 (Clopidogrel Fig 3)

FDA Label Image

Figure-1 (Clopidogrel Figure 01)

Not available.*

FDA Label Image

Figure-2 (Clopidogrel Figure 02)

This is a comparison of two medications: Placebo plus aspirin and Clopidogrel plus aspirin. There is a numerical value given which is likely a statistical measurement of effectiveness or side effects. There is also a graph showing data over a 12 month period. Other standard therapies were used in conjunction with these medications.*

FDA Label Image

Figure-4 (Clopidogrel Figure 04)

This is a description of a study evaluating the effectiveness of Clopidogrel compared to a placebo. The study involved patients who received aspirin and were followed up to 28 days after randomization. Results show a 7% reduction in proportional risk of death for patients taking Clopidogrel compared to placebo, with 1726 deaths (7.5%) in the Clopidogrel group and 1845 deaths (8.1%) in the placebo group.*

FDA Label Image

Figure-5 (Clopidogrel Figure 05)

FDA Label Image

Fig-7 (Clopidogrel Figure 07)

This text does not provide enough context to generate a useful description. It appears to be a table or graph showing data related to the drugs aspirin and clopidogrel, with a statistic of P=0.045 and a measure of months of follow-up. However, without more information, it is not possible to provide a meaningful interpretation.*

FDA Label Image

Figure-3 (Clopidogrel Figure 3)

This is a table depicting numerical data related to the effectiveness of a medication called Clopidogrel. The table contains various code numbers and percentages indicating the success rate of the medication compared to a placebo. The text also includes a reference to a place called Ratho G5.*

FDA Label Image

Figure-6 (Clopidogrel Figure 6)

FDA Label Image

Figure-8 (Clopidogrel Figure 8)

FDA Label Image

Structure (Clopidogrel Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.